Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
Clinical trial NCT07722754 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07722754
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-07-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.